The assumption underpinning nicotine reduction policy—that smokers and vapers consciously or unconsciously adjust their behavior to maintain a target blood-nicotine level—turns out to be more complicated than regulators may have anticipated. If puffing behavior is driven by throat and mouth sensation rather than central nervous system feedback, then simply lowering nicotine concentrations in e-cigarettes may not produce the intended dose reduction.
This secondary analysis pooled puff topography data across 129 participants drawn from two prior laboratory studies of electronic nicotine delivery systems (ENDS). Across 11 experimental conditions varying nicotine concentration (0–30 mg/mL), formulation type (freebase versus salt), and device power output, researchers tracked minute-by-minute puff duration and frequency over 60-minute sessions. A critical observation emerged: first-puff duration differed significantly across conditions before nicotine could plausibly have reached the central nervous system—effectively ruling out CNS-mediated titration as the immediate driver. Furthermore, puff duration remained stable throughout sessions regardless of whether participants were accumulating a high or low nicotine flux, and no compensatory lengthening of puffs occurred under low-nicotine conditions. Extracted nicotine dose rose linearly and proportionally with flux, implying users were not behaviorally self-correcting.
This open-loop sensory regulation model challenges decades of cigarette-derived thinking about nicotine titration, which formed the scientific bedrock for combustible tobacco reduction strategies now being transposed onto ENDS regulation. The finding is methodologically credible for a secondary analysis but carries inherent limitations: laboratory settings do not capture real-world ad-libitum use patterns, the 60-minute window may be too short to observe slower CNS feedback loops, and the participant pool was not large enough to stratify by dependence severity. Nonetheless, the implication is regulatory significant: product modifications targeting nicotine concentration alone may shift which sensory signals govern intake without necessarily reducing actual dose. This is an incremental but genuinely useful mechanistic contribution that deserves attention from both addiction researchers and public health policymakers designing ENDS standards.